Literature

FLUSH Promotions Announces KEEP PACE and '?QuestionMark?' memoir autobiography

Retrieved on: 
Thursday, April 4, 2024

Mark L. Mathews, CEO of FLUSH Promotions has been involved in the Autism Speaks community as a brand ambassador and Team Captain in major cities such as Florida, Indy, Chicago, and Detroit for the past seven years.

Key Points: 
  • Mark L. Mathews, CEO of FLUSH Promotions has been involved in the Autism Speaks community as a brand ambassador and Team Captain in major cities such as Florida, Indy, Chicago, and Detroit for the past seven years.
  • Often time's members of our society are overlooked or looked down upon for their issues without individuals fully understanding their story, or even asking about it.
  • Continuing the conversation is Mathews' newly launched Memoir entitled '?QuestionMark?
  • I AM a living example of the questions we ask are Self who we are and who are we trying to become ?QuestionMark?"

REGENATIVE LABS' LATEST PUBLISHED STUDY DEMONSTRATES THE SAFETY AND EFFICACY OF WHARTON'S JELLY CONNECTIVE TISSUE ALLOGRAFT FOR ROTATOR CUFF TEARS

Retrieved on: 
Thursday, April 4, 2024

PENSACOLA, Fla., April 4, 2024 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.

Key Points: 
  • PENSACOLA, Fla., April 4, 2024 /PRNewswire/ -- Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a study exhibiting the safety and efficacy of Wharton's Jelly connective tissue allograft for rotator cuff tears.
  • Patients in need of rotator cuff repairs often seek minimally invasive options, making Wharton's Jelly a promising alternative for musculoskeletal defects.
  • Utilizing the structural connective tissue allografts has allowed many patients to avoid surgery altogether and significantly improve their quality of life."
  • The study titled "Safety and Efficacy of Wharton's Jelly Connective Tissue Allograft for Rotator Cuff Tears," was published by MDPI and can be accessed in its entirety here.

MDJM Launches Cultural Business to Promote Integration Between Global East and West

Retrieved on: 
Thursday, April 4, 2024

LETHAM, Scotland, April 3, 2024 /PRNewswire/ -- MDJM LTD (Nasdaq: MDJH) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, has announced the launch of a new business that aims to promote cultural exchanges between the global East and West. By employing distinctively innovative approaches, the Company is set to free people from the drudgery of their mechanical daily lives, thereby awakening their vitality and sensitivity to global cultures.

Key Points: 
  • LETHAM, Scotland, April 3, 2024 /PRNewswire/ -- MDJM LTD (Nasdaq: MDJH) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, has announced the launch of a new business that aims to promote cultural exchanges between the global East and West.
  • To enhance the project's cultural and commercial value, MDJM is currently gathering a professional consulting team.
  • Exhibitions, forums, cultural and artistic commodity trading, customized cultural tourism, education and training, and more, will also be launched.
  • It will strongly promote global cultural diversity and inclusiveness and create new paths for the protection and dissemination of world cultural heritage while creating job opportunities and enhancing local economic development."

MDJM Launches Cultural Business to Promote Integration Between Global East and West

Retrieved on: 
Thursday, April 4, 2024

LETHAM, Scotland, April 4, 2024 /PRNewswire/ -- MDJM LTD (Nasdaq: MDJH) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, has announced the launch of a new business that aims to promote cultural exchanges between the global East and West. By employing distinctively innovative approaches, the Company is set to free people from the drudgery of their mechanical daily lives, thereby awakening their vitality and sensitivity to global cultures.

Key Points: 
  • LETHAM, Scotland, April 4, 2024 /PRNewswire/ -- MDJM LTD (Nasdaq: MDJH) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, has announced the launch of a new business that aims to promote cultural exchanges between the global East and West.
  • To enhance the project's cultural and commercial value, MDJM is currently gathering a professional consulting team.
  • Exhibitions, forums, cultural and artistic commodity trading, customized cultural tourism, education and training, and more, will also be launched.
  • It will strongly promote global cultural diversity and inclusiveness and create new paths for the protection and dissemination of world cultural heritage while creating job opportunities and enhancing local economic development."

Unprecedented Robert Frost Sesquicentennial Event Concludes After Five Days of Collaborations and Insights

Retrieved on: 
Wednesday, April 3, 2024

SAN DIEGO, April 3, 2024 /PRNewswire/ -- The recent Sesquicentennial Celebration commemorating the 150th birthday of Robert Frost, organized by the Robert Frost Society in collaboration with the Library Foundation SD, has drawn to a close.

Key Points: 
  • SAN DIEGO, April 3, 2024 /PRNewswire/ -- The recent Sesquicentennial Celebration commemorating the 150th birthday of Robert Frost, organized by the Robert Frost Society in collaboration with the Library Foundation SD, has drawn to a close.
  • This five-day event marked a once in a lifetime gathering of poets, scholars, and enthusiasts from around the world.
  • "We are pleased with the turnout and the positive feedback received throughout the Robert Frost Sesquicentennial Celebration," remarked Robert Bernard Hass, Executive Director of The Robert Frost Society.
  • For more information about The Robert Frost Society and membership inquiries, please visit www.robertfrostsociety.org .

A Murder in Augusta? Novelist Nathan Edmondson Premiers New Crime Thriller THE MASTER

Retrieved on: 
Wednesday, April 3, 2024

In THE MASTER, Edmondson crafts a tale of suspense that grabs readers from the first page.

Key Points: 
  • In THE MASTER, Edmondson crafts a tale of suspense that grabs readers from the first page.
  • Link to the book Press Kit here: https://www.nathanedmondson.com/the-master
    Augusta, Georgia is host to the most prestigious sporting event in the world.
  • Every April, Augusta's tournament invites the greatest golfers into the heart of the South to compete for the coveted green jacket.
  • Nathan Edmondson is the writer of many hit graphic novels, the ghostwriter and writing coach of major international publications.

BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS

Retrieved on: 
Monday, April 1, 2024

Additionally, Advanced Cell Diagnostics (ACD), part of Bio-Techne's Spatial Biology Division, was named winner of "The Innovation Award" in recognition of its RNAscope™ ISH technology and its role in helping to advance scientific discovery.

Key Points: 
  • Additionally, Advanced Cell Diagnostics (ACD), part of Bio-Techne's Spatial Biology Division, was named winner of "The Innovation Award" in recognition of its RNAscope™ ISH technology and its role in helping to advance scientific discovery.
  • The ELISA Kit Supplier of the Year award is a testament to the depth and breadth of the R&D Systems citation database, which covers reagent data for nearly one million ELISA kit products.
  • CiteAb's Innovation Award recognizes ACD's RNAscope HiPlex12 Flex Kit, which provides greater flexibility to researchers performing in situ spatial detection of target RNA.
  • The Innovation Award given to our ACD brand underscores our Spatial Biology team's dedication to enriching our customers' experiences and prioritizing researchers' needs."

Major Nationwide Research Findings on Faculty and Student Mindset to be Presented at the 2024 American Educational Research Association (AERA) Annual Meeting

Retrieved on: 
Thursday, March 28, 2024

NEW YORK, March 28, 2024 /PRNewswire-PRWeb/ -- Researchers from the Association of College and University Educators (ACUE) will present new faculty and student impact findings at the 2024 American Educational Research Association (AERA) Annual Meeting, the world's largest gathering of education researchers and a showcase for groundbreaking, innovative studies, April 11-14 in Philadelphia. This new research was selected by AERA for the rigor of its methodology and meaningfulness of the findings.

Key Points: 
  • This new research was selected by AERA for the rigor of its methodology and meaningfulness of the findings.
  • "Realizing Faculty Potential: Impacts of Faculty Development on Faculty's Mindsets and Self-Efficacy" will be presented on Saturday, April 13, from 7:45 to 9:15 a.m.
  • This study, funded through a research grant from the Bill & Melinda Gates Foundation, investigated the effectiveness of professional development courses focusing on faculty self-efficacy and mindset growth.
  • Faculty were surveyed four times over two years, including using mindset items originally developed by noted researcher Carol Dweck.

BEACON BIOSIGNALS EXPANDS SLEEP ANALYSIS CAPABILITIES WITH FDA CLEARANCE OF SLEEPSTAGEML

Retrieved on: 
Wednesday, March 27, 2024

BOSTON, March 27, 2024 /PRNewswire/ -- Beacon Biosignals announced today that it has received FDA 510(k) clearance for SleepStageML™️, an advanced machine learning software that automatically stages sleep from electroencephalogram (EEG) signals of clinical polysomnography (PSG) recordings to aid in the diagnosis and evaluation of sleep and sleep-related disorders. Beacon Biosignals is a health technology company focused on accelerating the development of therapies for neurological, psychiatric, and sleep disorders, and SleepStageML opens the door for more consistent, efficient, and precise sleep staging for these therapeutic areas. This latest clearance complements Beacon's previous FDA clearance of the Dreem 3S wearable headband and integrated algorithms, providing a comprehensive solution for precisely measuring sleep architecture across home and clinical settings.

Key Points: 
  • Beacon Biosignals is a health technology company focused on accelerating the development of therapies for neurological, psychiatric, and sleep disorders, and SleepStageML opens the door for more consistent, efficient, and precise sleep staging for these therapeutic areas.
  • This latest clearance complements Beacon's previous FDA clearance of the Dreem 3S wearable headband and integrated algorithms, providing a comprehensive solution for precisely measuring sleep architecture across home and clinical settings.
  • "With FDA clearances for both SleepStageML and Dreem 3S™ headband, Beacon now provides an unparalleled capability to measure sleep physiology whether studies are conducted in-home or in-clinic," said Jacob Donoghue, MD, PhD, CEO of Beacon Biosignals.
  • This FDA clearance represents a major milestone that bolsters Beacon Biosignals' powerful machine learning platform for rapidly analyzing large neurophysiology datasets.

Sanyou Bio: Sanyou's Intelligence-Enabled Innovative Biologics R&D Platform Leads in the New Era of Biological Drug Development

Retrieved on: 
Wednesday, March 27, 2024

This is the driving force behind Sanyou's development of an intelligence-enabled innovative biologics R&D platform.

Key Points: 
  • This is the driving force behind Sanyou's development of an intelligence-enabled innovative biologics R&D platform.
  • This system finds extensive applications across various domains, including research and development, data management, project management, quality control, and marketing.
  • By optimizing drug development processes and supporting intelligence-enabled decision-making, it comprehensively enhances R&D efficiency and accuracy, potentially playing a critical role in drug development.
  • In drug development, the modeling and prediction of drug developability analysis aims to comprehensively enhance the efficiency of the drug development process.